Atlas Trials

Phase 3b Study of Metvix NDL-PDT Versus Metvix c-PDT in Subjects With Actinic Keratoses

Clinical trial NCT01821391 · COMPLETED

Trial details

NCT number
NCT01821391
Sponsor
Galderma R&D
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Actinic Keratoses
Start date
2013-07-01
Primary completion
2014-01-01
Enrollment
131

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.